Pharmacist Investment Opportunity – Medical Cannabis Growing & Manufacturing
Medical cannabis and its health market potential was first brought to the attention of Australian pharmacists by i2P as far back as 2011. In that […]
Research Development
OMNS – Niacin Treatment of Schizophrenia Recent Research Confirms Abram Hoffer’s Original Work
(OMNS Dec 2, 2017) Schizophrenia is a devastating and complex disease that can include a variety of specific clinical conditions. Drugs to treat schizophrenia have […]
Pharmacy Disruptors – Amazon, Artificial Intelligence & Holographic Health Practitioners
Disruption, as we all know, is an inevitability that is to be feared. If that fear can be used to motivate a chain reaction of […]
Statin Therapy – A new Low?
I have a 90 year-old female patient who is physically OK but starting to face the reality of dementia. She showed me the “lovely” invitation […]
Health Literacy – A Concept for a Valid Direction for Community Pharmacy
Recently, I had a conversation with a health professional involved in the public health system. Research had emerged that large pockets of populations were experiencing […]
Soil Health Impacts Human Health – A New Perspective to Consider
Are pharmacists fully engaged with the full spectrum of health and an understanding of their patient’s lifestyle? Some information currently appearing in this edition of […]
Developing a Single Patient View
From the last business cycle to the current version, pharmacists and community pharmacies have undergone some profound experiences and rapid change. The transition to now […]
Micro-practice – Future Direction for Pharmacy
I2P has long proposed that pharmacy attracts two types of consumers – customers and patients. A little reflection will resolve this issue because clearly, customers […]
Design Thinking- What it is
Design thinking is not new but it has been evolving more rapidly since 1960 as a valid management process described as: * A unified framework […]
How Amazon Will Dominate Global Retail
Amazon is an innovation company that spends an extraordinary amount of money developing research on inventions that can eventually be implanted in the private homes […]